GSK4524101
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK4524101, covering 2026-04-24 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK), and Preliminary Anticancer Activity of GSK4524101 Alone or With Niraparib in Participants With Solid Tumors [Phase 1, Phase 2]